deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT01045226

Proton Radiation Therapy in Treating Patients With Prostate Cancer

A Phase II Trial of Proton Radiation Therapy of Using Standard Fractionation for Low-and Low-Intermediate Risk Adenocarcinoma of the Prostate

Sponsor: Abramson Cancer Center at Penn Medicine

Conditions Prostate Cancer
Interventions Proton Beam Radiation Therapy Quality-of-Life assessment Questionnaire Administration
Updated 14 times since 2017 Last updated: Jan 30, 2023 Started: Aug 31, 2009 Primary completion: Dec 31, 2020 Completion: Mar 17, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

participants are no longer being followed up.

Other terminated trials from Abramson Cancer Center at Penn Medicine

See all terminations from Abramson Cancer Center at Penn Medicine

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

Listed as NCT01045226, this NA trial focuses on Prostate Cancer and remains terminated or withdrawn. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 14 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~May 2019 · 7 months · monthly snapshot~May 2019 – ~May 2020 · 12 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2022 · 13 months · monthly snapshot~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshot~Jun 2022 – ~Mar 2023 · 9 months · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Apr 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Mar 2023 — Apr 2023 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  5. Jun 2022 — Mar 2023 [monthly]

    Active Not Recruiting NA

▶ Show 9 earlier versions

  1. Apr 2022 — Jun 2022 [monthly]

    Active Not Recruiting NA

  2. Mar 2021 — Apr 2022 [monthly]

    Active Not Recruiting NA

  3. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting NA

  4. May 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  5. May 2019 — May 2020 [monthly]

    Active Not Recruiting NA

    Status: Unknown Status → Active Not Recruiting

  6. Oct 2018 — May 2019 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  7. Jun 2018 — Oct 2018 [monthly]

    Recruiting NA

  8. Feb 2017 — Jun 2018 [monthly]

    Recruiting NA

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abramson Cancer Center at Penn Medicine
Data source: Abramson Cancer Center at Penn Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations